Pliant Therapeutics 

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$0
$2,270
$0
Gross Profit
-447
-448
1,135
-532
EBITDA
-42,044
-54,919
-48,440
-56,354
EBIT
-42,491
-55,367
-48,898
-56,886
Net Income
-43,300
-56,166
-49,732
-57,763
Net Change In Cash
0
0
2,270
0
Free Cash Flow
-40,715
-49,126
-47,871
-33,169
Cash
86,820
91,936
71,188
79,616
Basic Shares
61,386
61,222
60,538
60,730

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$1,580
$9,685
$7,572
Gross Profit
-2,125
1,580
9,685
7,572
EBITDA
-228,365
-158,228
-118,849
-18,451
EBIT
-189,219
-160,069
-122,530
-19,986
Net Income
-210,304
-161,336
-123,321
-17,907
Net Change In Cash
0
1,580
9,685
7,572
Cost of Revenue
-17,981
783
Free Cash Flow
-159,351
-117,282
-96,391
-77,396
Cash
71,188
63,234
33,685
51,665
Basic Shares
60,538
58,719
42,015
35,846

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$0.71
2025-03-31
-$0.92
2024-12-31
-$0.82